New research reveals that GLP-1 receptor agonists significantly lower mortality risk in older cancer patients with type 2 ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer compared to those with obesity who do not. Looking at 14 cancers, of which 13 ...

A new imaging approach reveals how dual agonist drugs like tirzepatide act on the pancreas and brain to regulate blood sugar and appetite.

As cancer progression has been linked with high glucose, adiposity, insulin resistance, and systemic inflammation, investigators studied several glucose-lowering drugs in relationship to cancer ...

Tom Brady shocked fans on Wednesday with a snap of himself standing next to his eldest son, Jack Moynahan, during a recent ...

New peptide drugs could take aim at a broader range of proteins that cause certain cancers, viral infections, and brain ...

After years of struggling with postpartum weight gain despite strict training and healthy eating, the 23-time Grand Slam ...

Serena Williams has long been subjected to ill-tasted criticism over her weight. Her recent collaboration with a healthy ...

Serena Williams, who was once celebrated for her curves, has confirmed that the reason for her newly trim figure is the use ...

“Semaglutide has been in the US for more than eight years now. In India also, the oral version of this molecule is there for ...

Serena Williams revealed she uses GLP-1 medication to aid weight loss after motherhood. This highlights a shift towards combining medicine with lifestyle for obesity management.

GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.